Some of the worst trolls just love harassing founders (esp. female founders) with 10-things-I-hate-about-China to derail conversations about their startup or their product or their journey to product-market-fit.
The world has never really reconciled the biological and chemical atrocities that went on in Asia during WWII and since, like they have in Europe. The Japanese used chemical gas attacks (munitions of unexploded gas are still found in China today) and did live vivesections on prisoners, amputating their appendages until there was nothing left. Hitler’s SS thought the atrocities so bad in China they asked for permission to intervene at several points. I doubt China has forgotten any of this, as they are expanding funding by several orders of magnitude into research on Japanese WWII atrocities.
To the north, Russia supposedly developed a type of chemical weapon even more powerful than nerve gas at one point in the 70’s. After the Cold War, while everyone was worried about nuclear weapons, Soviet bio and chemical scientists were easily available for hire and research. The Japanese cult that dumped Sarin into the Tokyo subway in 1996 had gotten far towards procuring many nerve agents as well as biological agents this way (developing powder to spread live agents that survived for weeks proved too difficult though).
Everyone talks about nuclear weapons, but biological, and to a lesser degree chemical, weapons have been under the radar for so long, governed by treaties that intellectually are still in 1918, that this needs to be looked at very seriously.
The article discusses academic labs as well as biotech companies openly hiring people from all over the world, and publishing their findings in journals. It talks about curing diseases, drug discovery, the lack of availability in China of some medications, and the career incentives for taking your biologist career to China. These are researchers publishing findings that everyone can read (modulo paywalls from some scientific publishers).
What this article is about: potentially taking a research job in China as a biologist (as a reader of Nature).
What this article is not about at all: shadowy military labs working on weapons.
Excerpt: "Just a decade ago, when China-born scientists with overseas experience began returning to the country, lured by their homeland’s fast growth and growing financial means, they found a drug industry dominated by generics. Undeterred, they got busy building the infrastructure for an industry capable of drug discovery and development, buoyed by substantial government support and a thriving economy."
For example, I'm not sure that in USA it would be possible for a terminally ill patient can opt-in to a dangerous/risky/experimental new form of treatment, while it could save thousands of others if successful.
At the same time, it seems like for biotech to have an explosion akin to the last fifty years explosion of computer technology, one would have to find a way to well and truly automate the processes involved. Last I looked, a vast amount of research is very much by hand, injecting drug into animal by hand, putting liquids in beakers by hand etc.
And part of it is living creatures are all different, and not just different in the two rocks on a beach or two toys out of a cheap mold are different. Living creatures, even two instance of the same creature, have functioning subsystems that function differently. And this is a multi-dimensional thing [1] . Custom tailored therapies attempt to take this into account but so far seem to have generally failed. I would speculate this is because humans have more than two or dimensions of difference between, even in subsystems like the immune system.
Edit: using AI to combine information on these systems that seem intractable in themselves also sounds promising - still many problem there also.
[1] Biochemical Individuality, Roger J. Williams
Relevant excerpt: "Innovent is hunting for employees who have worked in countries such as the United States, where the drug industries are more mature and people have had greater experience of overseeing the development of innovative drugs (see ‘What recruiters want’). “Ten per cent of our team are from overseas,” says Yu. “Returnees have first-hand experience with how drugs are developed and regulated in the United States.” This type of foreign experience will become increasingly important. In July, China became a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), signalling its intentions to mould its regulatory system in the shape of the ICH’s founding members: the United States, the European Union and Japan."
If that was the case, biotech would be booming from the congo to nepal.
Biotech is booming in china because they have the resources ( money, people and infrastructure ).
https://www.nature.com/articles/nbt0104-3 (over a decade old)
It's because they're fundamentally a lot less concerned about killing people in the process. There's a reasonable debate to be had on whether the US is too concerned with the risk aspect of making progress on biotech.
That's rather flippant, and I'd like to provide a counterpoint. Some neuroscience researchers held a town hall discussion in a major US city and also in a major Chinese city (on two different occasions) about bioethics, and one of the topics discussed was whether it was morally right or wrong (in the case of IVF) to screen for IQ, assuming we had reliable markers. So, same parents, no edits, but out of N embryos, instead of randomly selecting one, you choose one that's likely to be the smartest. Assuming it works reliably, is that wrong?
The U.S. audience was split approx. 50/50, with most of the objections about how it was going against God's will, or that it was "unnatural." The Chinese audience was all for it, and expressed surprise that the U.S. audience was split. Because if you could, and the technique was reliable, why wouldn't you?
Sometimes, it's useful to take a second look at our cultural biases.
Big pharma organizations in the US and Europe have been cutting r&d workforces for years, and most small biotech startups that are filling the innovation gap hire execs with 20+ years of experience to design and manage the research and outsourcing the actual work to china. Wuxi, a large contract research org in china, employs like 1-2,000 discovery chemists. I think Pfizer employs maybe 100
